| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +1.3M | 73.7% | $46.00 | +$60M |
| Sells | 8 | -465K | 26.3% | $47.87 | -$22.3M |
| Net | -7 | +839K | 47.4% | +$37.7M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Thilo Schroeder | Director | $350M | +$60M | +20.7% | Dec 5, 2024 |
| Third Rock Ventures III, L.P. | 10%+ Owner | $138M | Jun 8, 2022 | ||
| Alexis Borisy | Director | $93.1M | Jun 26, 2025 | ||
| Mark A. Goldsmith | President and Chief Executive Officer, Director | $38.6M | -$7.53M | -16.3% | Sep 16, 2025 |
| Stephen Michael Kelsey | President, Research and Development | $13M | -$8.12M | -38.4% | Sep 16, 2025 |
| Margaret Horn | Chief Operating Officer | $6.69M | -$3.19M | -32.3% | Sep 16, 2025 |
| Jack Anders | Chief Financial Officer | $5.09M | -$1.29M | -20.2% | Sep 16, 2025 |
| Xiaolin Wang | EVP, Clinical Development | $4.14M | Mar 17, 2025 | ||
| Wei Lin | Chief Medical Officer | $4.05M | -$186K | -4.38% | Sep 16, 2025 |
| Sandra Horning | Director | $3.84M | Jun 26, 2025 | ||
| Lorence H. Kim | Director | $2.91M | Jun 26, 2025 | ||
| Jeff Cislini | General Counsel | $2.23M | -$1.42M | -38.9% | Sep 24, 2025 |
| Elizabeth M. Anderson | Director | $2M | Jun 26, 2025 | ||
| Neil Exter | Director | $1.32M | Jun 16, 2022 | ||
| Flavia Borellini | Director | $996K | Jun 26, 2025 | ||
| Sushil Patel | Director | $919K | -$271K | -22.8% | Jun 26, 2025 |
| Vincent A. Miller | Director | $641K | Jun 22, 2021 | ||
| Barbara Weber | Director | $627K | -$250K | -28.5% | Oct 8, 2024 |
| Eric Schmidt | Director | $574K | Jun 8, 2023 | ||
| Frank Clyburn | Director | $388K | Jun 26, 2025 | ||
| Third Rock Ventures II, L.P. | 10%+ Owner | $349K | Jun 3, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|